NO883612D0 - Fremgangsmaate for fremstilling av nye, terapeutisk aktive estere en 9-(2-hydroksyetoksymetyl)guanin. - Google Patents

Fremgangsmaate for fremstilling av nye, terapeutisk aktive estere en 9-(2-hydroksyetoksymetyl)guanin.

Info

Publication number
NO883612D0
NO883612D0 NO883612A NO883612A NO883612D0 NO 883612 D0 NO883612 D0 NO 883612D0 NO 883612 A NO883612 A NO 883612A NO 883612 A NO883612 A NO 883612A NO 883612 D0 NO883612 D0 NO 883612D0
Authority
NO
Norway
Prior art keywords
hydroxyetoxymethyl
guanine
procedure
preparation
new therapeutic
Prior art date
Application number
NO883612A
Other languages
English (en)
Other versions
NO883612L (no
NO167805C (no
NO167805B (no
Inventor
Thomas Anthony Krenitsky
Lilla Marie Beauchamp
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26292613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO883612(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB878719367A external-priority patent/GB8719367D0/en
Priority claimed from GB878725939A external-priority patent/GB8725939D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO883612D0 publication Critical patent/NO883612D0/no
Publication of NO883612L publication Critical patent/NO883612L/no
Publication of NO167805B publication Critical patent/NO167805B/no
Publication of NO167805C publication Critical patent/NO167805C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
NO883612A 1987-08-15 1988-08-12 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive estere av 9-(2-hydroksyetoksymetyl)guanin. NO167805C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878719367A GB8719367D0 (en) 1987-08-15 1987-08-15 Therapeutic compounds
GB878725939A GB8725939D0 (en) 1987-11-05 1987-11-05 Therapeutic compounds

Publications (4)

Publication Number Publication Date
NO883612D0 true NO883612D0 (no) 1988-08-12
NO883612L NO883612L (no) 1989-02-16
NO167805B NO167805B (no) 1991-09-02
NO167805C NO167805C (no) 1991-12-11

Family

ID=26292613

Family Applications (2)

Application Number Title Priority Date Filing Date
NO883612A NO167805C (no) 1987-08-15 1988-08-12 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive estere av 9-(2-hydroksyetoksymetyl)guanin.
NO1996015C NO1996015I1 (no) 1987-08-15 1996-12-17 Valacyclovir

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO1996015C NO1996015I1 (no) 1987-08-15 1996-12-17 Valacyclovir

Country Status (30)

Country Link
EP (2) EP0308065B1 (no)
JP (2) JPH0662623B2 (no)
KR (2) KR960002849B1 (no)
CN (1) CN1033701C (no)
AP (2) AP55A (no)
AT (1) ATE138660T1 (no)
AU (1) AU612393C (no)
CS (1) CS276903B6 (no)
CY (1) CY1833A (no)
DE (1) DE3855333T2 (no)
DK (2) DK170045B1 (no)
ES (1) ES2087639T3 (no)
FI (1) FI89713C (no)
GR (1) GR3020372T3 (no)
HU (1) HU201071B (no)
IE (1) IE65551B1 (no)
IL (1) IL87434A (no)
LU (1) LU88746I2 (no)
LV (1) LV5264A3 (no)
MC (1) MC1968A1 (no)
MX (1) MX9203418A (no)
MY (1) MY103760A (no)
NL (1) NL960001I2 (no)
NO (2) NO167805C (no)
NZ (1) NZ225809A (no)
PL (1) PL158285B1 (no)
PT (1) PT88261B (no)
SA (1) SA95160244B1 (no)
SG (1) SG26346G (no)
SU (1) SU1634138A3 (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP55A (en) * 1987-08-15 1989-09-26 The Wellcome Foundation Ltd Therapeutic Acyclic Nucleosides
GB8816760D0 (en) * 1988-07-14 1988-08-17 Wellcome Found Therapeutic compounds
US5043339A (en) * 1988-12-19 1991-08-27 Burroughs Wellcome Co. Antiviral compounds
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
DE4008858A1 (de) * 1990-03-20 1991-09-26 Hoechst Ag Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel
ATE199719T1 (de) * 1993-06-10 2001-03-15 Rolabo Sl Verfahren zur herstellung von aminosäureester von nukleosid analogen
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
GB9320316D0 (en) * 1993-10-01 1993-11-17 Smithkline Beecham Plc Pharmaceuticals
TW282470B (no) * 1993-11-18 1996-08-01 Ajinomoto Kk
EP0665229B1 (en) * 1994-02-01 1999-11-17 Ajinomoto Co., Inc. Process for the production of nucleic acid base derivatives
US5856481A (en) * 1994-07-28 1999-01-05 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
GB9501178D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Guanine derivative
GB9501142D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Compounds for use in medicine
DE19536164A1 (de) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 9-[(2-Hyroxyethoxy)methyl]guanin (Acyclovir)
PT874631E (pt) * 1996-01-19 2004-04-30 Glaxo Group Ltd Utilizacao de valaciclovir para a manufactura de um medicamento para o tratamento de herpes genital por aplicacao diaria unica
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
AU1543797A (en) * 1996-01-26 1997-08-20 F. Hoffmann-La Roche Ag Process for preparing purine derivatives
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
IT1283447B1 (it) * 1996-07-18 1998-04-21 Ind Chimica Srl Processo di preparazione del valaciclovir e relativi intermedi
KR20000070223A (ko) * 1997-01-17 2000-11-25 에가시라 구니오 신규한 ｚ-발라사이클로비르 결정
WO1999059574A1 (en) * 1998-05-21 1999-11-25 Magainin Pharmaceuticals, Inc. A method for stimulation of defensin production by exposure to isoleucin
EP1436295A4 (en) * 2001-09-07 2007-07-11 Teva Pharma CRISTALLINE FORMS OF VALACYCLOVIR HYDROCHLORIDE
EP1517678A2 (en) 2002-06-24 2005-03-30 Ranbaxy Laboratories Limited Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050043329A1 (en) * 2002-09-06 2005-02-24 Shlomit Wizel Crystalline forms of valacyclovir hydrochloride
CN1309732C (zh) * 2002-10-28 2007-04-11 南京长澳医药科技有限公司 6－烷氧基－2’，3’－双脱氧鸟嘌呤核苷的制备方法
EP2014660A3 (en) * 2003-06-02 2009-07-15 Teva Pharmaceutical Industries Ltd Novel crystalline forms of valacyclovir hydrochloride
CN1331471C (zh) * 2003-09-22 2007-08-15 陈云芳 盐酸万乃洛韦软胶囊组合物
KR20060117355A (ko) * 2004-01-21 2006-11-16 테바 파마슈티컬 인더스트리즈 리미티드 발라시클로버 염산염의 제조 방법
GB2413017A (en) * 2004-04-06 2005-10-12 Ford Global Tech Llc An electrical connector for a vehicle
WO2006035452A1 (en) * 2004-09-27 2006-04-06 Matrix Laboratories Ltd Novel pseudomorph of valaciclovir hydrochloride
WO2006127217A2 (en) 2005-05-25 2006-11-30 Eli Lilly And Company Cyclopropanecarboxylate esters of acyclovir
EP1746098A1 (en) 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
CN101456859B (zh) * 2009-01-06 2011-07-20 华南理工大学 抗病毒药物缬昔洛韦的制备方法
WO2011158252A1 (en) 2010-06-15 2011-12-22 Matrix Laboratories Ltd Process for the preparation of valacyclovir hydrochloride polymorphic form ii
CN102850354B (zh) * 2012-10-10 2014-07-23 山东金城医药化工股份有限公司 高纯度cbz-万乃洛韦的制备方法
CN106632335A (zh) * 2016-12-27 2017-05-10 河南康达制药有限公司 一种盐酸伐昔洛韦的制备方法
RU2750867C1 (ru) * 2020-05-18 2021-07-05 Александр Сергеевич Самойлов Производные гуанина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
DE3534774A1 (de) * 1985-09-30 1987-04-02 Robugen Gmbh Nucleosid-analoge verbindungen mit antiviraler aktivitaet, verfahren zu deren herstellung sowie arzneimittel mit antiviraler wirkung
AP55A (en) * 1987-08-15 1989-09-26 The Wellcome Foundation Ltd Therapeutic Acyclic Nucleosides

Also Published As

Publication number Publication date
PT88261A (pt) 1989-06-30
SU1634138A3 (ru) 1991-03-07
CS276903B6 (en) 1992-09-16
IE882463L (en) 1989-02-15
IL87434A (en) 1993-06-10
JPH07113025B2 (ja) 1995-12-06
AP160A (en) 1991-11-18
NL960001I1 (nl) 1996-03-01
HU201071B (en) 1990-09-28
SA95160244B1 (ar) 2006-10-02
AP8800099A0 (en) 1988-08-01
KR960004940B1 (ko) 1996-04-18
FI89713C (fi) 1993-11-10
JPH03115284A (ja) 1991-05-16
LU88746I2 (fr) 1996-10-04
MX9203418A (es) 1992-07-01
DK451388D0 (da) 1988-08-12
NO883612L (no) 1989-02-16
ES2087639T3 (es) 1996-07-16
KR890003761A (ko) 1989-04-17
NO167805C (no) 1991-12-11
CN1033701C (zh) 1997-01-01
FI89713B (fi) 1993-07-30
IE65551B1 (en) 1995-11-01
EP0308065A3 (en) 1989-09-27
NZ225809A (en) 1991-07-26
EP0308065A2 (en) 1989-03-22
CS8805594A2 (en) 1990-06-13
DK451388A (da) 1989-02-16
DK170045B1 (da) 1995-05-08
MC1968A1 (fr) 1989-09-29
DK82694A (da) 1994-07-08
PL158285B1 (en) 1992-08-31
GR3020372T3 (en) 1996-09-30
PT88261B (pt) 1995-03-01
DK170803B1 (da) 1996-01-22
IL87434A0 (en) 1989-01-31
CN1032538A (zh) 1989-04-26
AU612393C (en) 2006-08-17
NO1996015I1 (no) 1996-12-17
CY1833A (en) 1995-12-01
HUT47935A (en) 1989-04-28
NO167805B (no) 1991-09-02
SG26346G (en) 1995-09-01
AU612393B2 (en) 1991-07-11
EP0596542B1 (en) 1996-05-29
NL960001I2 (nl) 1996-11-01
PL274215A1 (en) 1990-02-19
LV5264A3 (lv) 1993-10-10
FI883757A0 (fi) 1988-08-12
AU2097888A (en) 1989-02-16
EP0308065B1 (en) 1995-01-04
MY103760A (en) 1993-09-30
ATE138660T1 (de) 1996-06-15
AP55A (en) 1989-09-26
JPH0662623B2 (ja) 1994-08-17
DE3855333T2 (de) 1996-12-05
EP0596542A1 (en) 1994-05-11
FI883757A (fi) 1989-02-16
KR960002849B1 (ko) 1996-02-27
JPS6468373A (en) 1989-03-14
DE3855333D1 (de) 1996-07-04

Similar Documents

Publication Publication Date Title
NO883612D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive estere en 9-(2-hydroksyetoksymetyl)guanin.
NO883974D0 (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO884154L (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO884231D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazopyridin-derivater.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO166362C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO168361C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye adenosinderivater
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO881613D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklisk-alifatiske karboksamider.
NO165545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater.
NO167287C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-isoxazol-beta-carboliner.
NO891723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO881190D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 9- (beta-d-deoxyribofuranosyl)-mucleosider.
NO891114L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO883959L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.

Legal Events

Date Code Title Description
MK1K Patent expired